Chemokine CX3C motif ligand 1 (CX3CL1; fractalkine); HER2 (EGFR2; ErbB2; neu) BriefCommunication Pages: 677 - 677
V-set domain containing T cell activation inhibitor 1 (VTCN1; B7-H4) BriefCommunication Pages: 680 - 680
TNF-like weak inducer of apoptosis receptor (TNFRSF12A; TWEAKR; FN14) BriefCommunication Pages: 682 - 682
Staphylococcus leukotoxin AB (lukAB); complement receptor 3 (CR3; CD11b); MAC-1 (CD11b-CD18) BriefCommunication Pages: 688 - 688
Cyclin dependent kinase 5 (CDK5); glycogen synthase kinase 3β (GSK3B) BriefCommunication Pages: 689 - 689
Mannosyl (α-1,6-)-glycoprotein β-1,6-N-acetyl-glucosaminyltransferase isozyme B (MGAT5B) BriefCommunication Pages: 691 - 691
Calcium channel voltage-dependent L type-α 1C subunit (CACNA1C; Cav1.2) BriefCommunication Pages: 692 - 692
Discs large homolog-associated protein 3 (DLGAP3; SAPAP3); melanocortin 4 receptor (MC4R); BriefCommunication Pages: 696 - 696
An algorithm for more accurate identification of cancer-associated mutations in genome sequencing studies BriefCommunication Pages: 699 - 699
Tissue-specific drug delivery with antibody-coated, polymer, rod-shaped nanoparticles (nanorods) BriefCommunication Pages: 703 - 703
High-yield generation of functional neurons from human induced pluripotent stem (iPS) cells BriefCommunication Pages: 705 - 705
Universal, chimeric antigen receptor (CAR)-based T cell therapy using zinc finger nuclease (ZFN) T cell editing BriefCommunication Pages: 708 - 708